Drawing upon the recent resurgence of biological criminology, several studies have highlighted a critical role for genetic factors in the ontogeny of antisocial and violent conduct. In particular, converging lines of evidence have documented that these maladaptive manifestations of aggression are influenced by monoamine oxidase A (MAOA), the enzyme that catalyzes the degradation of brain serotonin, norepinephrine and dopamine. The interest on the link between MAOA and aggression was originally sparked by Han Brunner's discovery of a syndrome characterized by marked antisocial behaviors in male carriers of a nonsense mutation of this gene. Subsequent studies showed that MAOA allelic variants associated with low enzyme activity moderate the impact of earlylife maltreatment on aggression propensity. In spite of overwhelming evidence pointing to the relationship between MAOA and aggression, the neurobiological substrates of this link remain surprisingly elusive; very little is also known about the interventions that may reduce the severity of pathological aggression in genetically predisposed subjects. Animal models offer a unique experimental tool to investigate these issues; in particular, several lines of transgenic mice harboring total or partial loss-of-function Maoa mutations have been shown to recapitulate numerous psychological and neurofunctional endophenotypes observed in humans. This review summarizes the current knowledge on the link between MAOA and aggression; in particular, we will emphasize how an integrated translational strategy coordinating clinical and preclinical research may prove critical to elucidate important aspects of the pathophysiology of aggression, and identify potential targets for its diagnosis, prevention and treatment.
Introduction
Aggression is characterized by a multifaceted array of adaptive responses aimed at inflicting harm to another organism for offensive or defensive purposes. From an evolutionary perspective, aggressive behaviors are instrumental to a large number of vital functions, including the attainment of resources, determent of competitors and organization of social hierarchies (Buss and Shackelford, 1997) . Given the relevance of these tasks for survival and offspring fitness, it is not surprising that human aggression is deeply rooted in genetic foundations (Ferguson, 2010) . Consistent with this premise, multiple studies have documented the high heritability of pathological aggression, defined as a set of maladaptive and exaggerated hostile manifestations, such as antisocial and violent behaviors (Grove et al., 1990; diLalla and Gottesman, 1991; Miles and Carey, 1997; Rhee and Waldman, 2002) . The best-validated genetic basis of aggression and antisocial behavior is the gene MAOA, located on the short arm of the X chromosome (Xp11.4-p11.23) (Bach et al., 1988; Grimsby et al., 1990) and encoding monoamine oxidase A. This enzyme catalyzes the degradation of key brain neurotransmitters involved in pathological aggression, such as serotonin (5-hydroxytryptamine; 5-HT), and the two catecholamines norepinephrine and dopamine (Bortolato et al., 2008) . While other genes involved in monoamine neurotransmission pathways have been implicated in antisocial behaviors (Ferguson and Beaver, 2009) , the unique reputation of MAOA lies in the large number of independent studies supporting its role in aggression. For all the popularity of this gene -which has even led to occasional misinterpretations from the media and criminal justice system 
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